Cargando…
Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
BACKGROUND: Precise methods for postoperative risk stratification to guide the administration of adjuvant chemotherapy (ACT) in localized colorectal cancer (CRC) are still lacking. Here, we conducted a prospective, observational, and multicenter study to investigate the utility of circulating tumor...
Autores principales: | Chen, Gong, Peng, Junjie, Xiao, Qian, Wu, Hao-Xiang, Wu, Xiaojun, Wang, Fulong, Li, Liren, Ding, Peirong, Zhao, Qi, Li, Yaqi, Wang, Da, Shao, Yang, Bao, Hua, Pan, Zhizhong, Ding, Ke-Feng, Cai, Sanjun, Wang, Feng, Xu, Rui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130394/ https://www.ncbi.nlm.nih.gov/pubmed/34001194 http://dx.doi.org/10.1186/s13045-021-01089-z |
Ejemplares similares
-
Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial
por: Wang, Fulong, et al.
Publicado: (2018) -
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
por: Wang, Fulong, et al.
Publicado: (2023) -
Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis
por: Peng, Jianhong, et al.
Publicado: (2017) -
Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020) -
Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
por: Peng, Jianhong, et al.
Publicado: (2017)